Home/Filings/4/0001225208-17-016298
4//SEC Filing

Collins Timothy P 4

Accession 0001225208-17-016298

CIK 0000009892other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 7:01 PM ET

Size

23.7 KB

Accession

0001225208-17-016298

Insider Transaction Report

Form 4
Period: 2017-10-12
Collins Timothy P
Group Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2017-10-12$168.87/sh+9,418$1,590,37177,806 total
  • Sale

    Common Stock

    2017-10-12$322.03/sh55,818$17,974,88626,646 total
  • Exercise/Conversion

    Option (Right to Buy)

    2017-10-1223,9100 total
    Exercise: $97.69Exp: 2022-12-12Common Stock (23,910 underlying)
  • Exercise/Conversion

    Common Stock

    2017-10-12$136.37/sh+17,832$2,431,75068,388 total
  • Exercise/Conversion

    Common Stock

    2017-10-12$186.43/sh+4,390$818,40682,196 total
  • Exercise/Conversion

    Option (Right to Buy)

    2017-10-124,39013,172 total
    Exercise: $186.43Exp: 2025-12-09Common Stock (4,390 underlying)
  • Exercise/Conversion

    Common Stock

    2017-10-12$84.58/sh+268$22,66682,464 total
  • Exercise/Conversion

    Common Stock

    2017-10-12$97.69/sh+23,910$2,335,64850,556 total
  • Exercise/Conversion

    Option (Right to Buy)

    2017-10-129,4189,419 total
    Exercise: $168.87Exp: 2024-12-10Common Stock (9,418 underlying)
  • Exercise/Conversion

    Option (Right to Buy)

    2017-10-1217,8325,944 total
    Exercise: $136.37Exp: 2023-12-11Common Stock (17,832 underlying)
  • Exercise/Conversion

    Option (Right to Buy)

    2017-10-122680 total
    Exercise: $84.58Exp: 2021-12-14Common Stock (268 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    355.914
Footnotes (8)
  • [F1]Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
  • [F2]Represents the weighted average sales price for price increments ranging from $322.00 to $322.16. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  • [F3]Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  • [F4]Of this option grant 4,390 options fully vested and the remaining options vest in three annual installments beginning on December 9, 2017.
  • [F5]Of this option grant 9,418 options fully vested and the remaining options vest in two annual installments beggining on December 10, 2017.
  • [F6]Of this option grant 17,832 options fully vested and the remaining options vest on December 11, 2017.
  • [F7]Options fully vested and are currently exercisable.
  • [F8]Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).

Documents

1 file

Issuer

BARD C R INC /NJ/

CIK 0000009892

Entity typeother

Related Parties

1
  • filerCIK 0001462450

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:01 PM ET
Size
23.7 KB